Annual Accounts Receivable
N/A
December 31, 2024
Summary
- SMMT annual accounts receivable is not available.
Performance
SMMT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
December 31, 2024
Summary
- SMMT quarterly accounts receivable is not available.
Performance
SMMT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SMMT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
SMMT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Summit Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $349.00 K(-76.2%) | $349.00 K(+149.3%) |
| Sep 2022 | - | $140.00 K(-41.2%) |
| Jun 2022 | - | $238.00 K(-72.6%) |
| Mar 2022 | - | $870.00 K(-40.6%) |
| Dec 2021 | $1.46 M(+342.3%) | $1.46 M(-36.1%) |
| Sep 2021 | - | $2.29 M(+117.5%) |
| Jun 2021 | - | $1.05 M(+135.6%) |
| Mar 2021 | - | $447.00 K(+35.0%) |
| Dec 2020 | $331.00 K(-38.8%) | - |
| Dec 2020 | - | $331.00 K(-91.9%) |
| Sep 2020 | - | $4.08 M(-66.3%) |
| Mar 2020 | - | $12.10 M(+4.7%) |
| Dec 2019 | $541.00 K(-75.1%) | - |
| Oct 2019 | - | $11.55 M(-11.1%) |
| Jul 2019 | - | $12.99 M(+497.9%) |
| Jan 2019 | $2.17 M(-86.2%) | - |
| Jan 2019 | - | $2.17 M(-86.2%) |
| Jan 2018 | $15.69 M | - |
| Jan 2018 | - | $15.69 M(+430.5%) |
| Apr 2015 | - | $2.96 M(+38.0%) |
| Oct 2014 | - | $2.14 M(-1.7%) |
| Jul 2014 | - | $2.18 M(+438.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2013 | - | $405.40 K(+403.0%) |
| Jan 2013 | $80.60 K(+9.2%) | - |
| Jan 2013 | - | $80.60 K(-70.7%) |
| Jul 2012 | - | $274.90 K(+272.5%) |
| Jan 2012 | $73.80 K(+45.8%) | - |
| Jan 2012 | - | $73.80 K(-90.8%) |
| Jul 2011 | - | $805.80 K(+1492.5%) |
| Jan 2011 | $50.60 K(-22.7%) | - |
| Jan 2011 | - | $50.60 K(-80.7%) |
| Jul 2010 | - | $262.20 K(+300.3%) |
| Jan 2010 | $65.50 K(-93.0%) | - |
| Jan 2010 | - | $65.50 K(-87.6%) |
| Jul 2009 | - | $529.60 K(-43.6%) |
| Jan 2009 | $938.30 K(+149.7%) | - |
| Jan 2009 | - | $938.30 K(-63.9%) |
| Jul 2008 | - | $2.60 M(+592.3%) |
| Jan 2008 | $375.80 K(-32.3%) | - |
| Jan 2008 | - | $375.80 K(-90.0%) |
| Jul 2007 | - | $3.76 M(+576.7%) |
| Jan 2007 | $555.10 K(+141.0%) | - |
| Jan 2007 | - | $555.10 K(+141.0%) |
| Jan 2006 | $230.30 K(+205.8%) | - |
| Jan 2006 | - | $230.30 K(-69.5%) |
| Jul 2005 | - | $754.40 K(+901.9%) |
| Jan 2005 | $75.30 K | - |
| Jan 2005 | - | $75.30 K |
FAQ
- What is the all time high annual accounts receivable for Summit Therapeutics?
- What is the all time high quarterly accounts receivable for Summit Therapeutics?
What is the all time high annual accounts receivable for Summit Therapeutics?
Summit Therapeutics all-time high annual accounts receivable is $15.69 M
What is the all time high quarterly accounts receivable for Summit Therapeutics?
Summit Therapeutics all-time high quarterly accounts receivable is $15.69 M